Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Ribavirin triphosphate (RBV-TP) was dephosphorylated in vitr...

Class:IdSummation:9754908
_displayNameRibavirin triphosphate (RBV-TP) was dephosphorylated in vitr...
_timestamp2021-10-05 09:34:17
created[InstanceEdit:9755067] Stephan, Ralf, 2021-10-05
textRibavirin triphosphate (RBV-TP) was dephosphorylated in vitro by recombinant ITP triphosphatase (ITPAse, ITPA) to a similar extent as its naturally occurring substrate ITP. Reduced ITPase activity in one third of humans causes increased intracellular levels of RBV-TP, leading to increased treatment efficacy (Nystrom et al, 2018; Tanaka et al, 2018). Polymorphisms in the gene encoding ITPase (ITPA) have been associated with protection against ribavirin-induced anemia (Fellay et al, 2010).
(summation)[Reaction:9755030] ITPA dimer dephosphorylates RBV-TP to RBV-MP [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Ribavirin triphosphate (RBV-TP) was dephosphorylated in vitr... (9754908)